$WT

Lilien R Jarrett sold $737K of WT

Lilien R Jarrett (President and COO) sold 30,000 shares of WisdomTree, Inc. (WT) at $24.56 ($0.74M total) on 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lilien R Jarrett
Published Sep 10, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WT
Neutral
medium confidence
Mentioned
$WT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WTNeutralLow
01

Why it matters

Provides fresh data on insider holdings; modest impact on market perception.

02

Market read

Insider sale is a routine disclosure with limited trading relevance.

03

What to watch

The 10b5‑1 plan indicates the sale was pre‑planned, reducing informational value.

Relevance 4/10Novelty 3/10Timing: post‑market 2026‑09‑09

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$WTNeutralMedium confidence
Context

President and COO Lilien R Jarrett sold 30,000 shares for $736,800 via a 10b5‑1 plan.

Expected impact

Minor downward pressure, likely within normal volatility.

Evidence & confidence

Sale represents ~2.8% of insider's remaining position; not large enough to drive price alone.

Market effects

No immediate sector impact; insider activity is company‑specific.

Limited to U.S. equity market participants tracking WisdomTree.

Low global relevance.

Counterpoint

Sale could be routine liquidity management under a pre‑arranged plan, not a bearish signal.

Key entities

  • WisdomTree, Inc.

    US‑listed asset manager (ticker WT).

  • Lilien R Jarrett

    President and COO of WisdomTree.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.